Home/Filings/4/0001437749-23-000534
4//SEC Filing

Ludwig Jeffrey Jerome 4

Accession 0001437749-23-000534

CIK 0001401667other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:36 PM ET

Size

5.2 KB

Accession

0001437749-23-000534

Insider Transaction Report

Form 4
Period: 2023-01-03
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2023-01-03$4.18/sh6,568$27,44058,057 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.1922, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Issuer

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667

Entity typeother

Related Parties

1
  • filerCIK 0001807133

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:36 PM ET
Size
5.2 KB